543207 — Natural Biocon (India) Income Statement
0.000.00%
- IN₹323.32m
- IN₹325.70m
- IN₹83.48m
- 32
- 16
- 54
- 22
Annual income statement for Natural Biocon (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.32 | 4.82 | 12.5 | 135 | 83.5 |
Cost of Revenue | |||||
Gross Profit | 0.431 | 1.94 | 3.75 | 8.65 | 9.54 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.28 | 3.93 | 10.1 | 133 | 82.9 |
Operating Profit | 0.043 | 0.887 | 2.48 | 2.25 | 0.596 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.037 | 0.879 | 2.47 | 2.25 | 0.596 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.028 | 0.659 | 1.79 | 1.53 | 0.446 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.028 | 0.659 | 1.79 | 1.53 | 0.446 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.028 | 0.659 | 1.79 | 1.53 | 0.446 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.002 | 0.058 | 0.157 | 0.134 | 0.02 |